![The influence of verapamil on the pharmacokinetics of the pan-HER tyrosine kinase inhibitor neratinib in rats: the role of P-glycoprotein-mediated efflux | SpringerLink The influence of verapamil on the pharmacokinetics of the pan-HER tyrosine kinase inhibitor neratinib in rats: the role of P-glycoprotein-mediated efflux | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10637-022-01314-7/MediaObjects/10637_2022_1314_Figa_HTML.png)
The influence of verapamil on the pharmacokinetics of the pan-HER tyrosine kinase inhibitor neratinib in rats: the role of P-glycoprotein-mediated efflux | SpringerLink
![Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis | Breast Cancer Research | Full Text Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13058-019-1177-1/MediaObjects/13058_2019_1177_Fig3_HTML.png)
Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis | Breast Cancer Research | Full Text
P-Glycoprotein (ABCB1/MDR1) Controls Brain Penetration and Intestinal Disposition of the PARP1/2 Inhibitor Niraparib | Molecular Pharmaceutics
![Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis | Breast Cancer Research | Full Text Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13058-019-1177-1/MediaObjects/13058_2019_1177_Fig4_HTML.png)
Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis | Breast Cancer Research | Full Text
![Breast Cancer Patients with Brain Metastasis Seen to Benefit from Neratinib and Xeloda Combo in Trial Breast Cancer Patients with Brain Metastasis Seen to Benefit from Neratinib and Xeloda Combo in Trial](https://breastcancer-news.com/wp-content/uploads/2017/06/shutterstock_390249514.jpg)
Breast Cancer Patients with Brain Metastasis Seen to Benefit from Neratinib and Xeloda Combo in Trial
![Cancers | Free Full-Text | Anti-Hormonal Therapy in Breast Cancer and Its Effect on the Blood-Brain Barrier Cancers | Free Full-Text | Anti-Hormonal Therapy in Breast Cancer and Its Effect on the Blood-Brain Barrier](https://www.mdpi.com/cancers/cancers-14-05132/article_deploy/html/images/cancers-14-05132-g001.png)
Cancers | Free Full-Text | Anti-Hormonal Therapy in Breast Cancer and Its Effect on the Blood-Brain Barrier
![IJMS | Free Full-Text | Navigating the Blood–Brain Barrier: Challenges and Therapeutic Strategies in Breast Cancer Brain Metastases IJMS | Free Full-Text | Navigating the Blood–Brain Barrier: Challenges and Therapeutic Strategies in Breast Cancer Brain Metastases](https://www.mdpi.com/ijms/ijms-24-12034/article_deploy/html/images/ijms-24-12034-g001.png)
IJMS | Free Full-Text | Navigating the Blood–Brain Barrier: Challenges and Therapeutic Strategies in Breast Cancer Brain Metastases
![Potential Transdermal Cancer Treatment Through Blood Brain Barrier with a Crystalline Neratinib Salt Potential Transdermal Cancer Treatment Through Blood Brain Barrier with a Crystalline Neratinib Salt](https://www.cancertreatmentjournal.com/articles/images/JCTD-21-1197-fig1.png)
Potential Transdermal Cancer Treatment Through Blood Brain Barrier with a Crystalline Neratinib Salt
![Cancers | Free Full-Text | Breast Cancer Brain Metastasis—Overview of Disease State, Treatment Options and Future Perspectives Cancers | Free Full-Text | Breast Cancer Brain Metastasis—Overview of Disease State, Treatment Options and Future Perspectives](https://pub.mdpi-res.com/cancers/cancers-13-01078/article_deploy/html/images/cancers-13-01078-ag.png?1614908351)
Cancers | Free Full-Text | Breast Cancer Brain Metastasis—Overview of Disease State, Treatment Options and Future Perspectives
![Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis | Breast Cancer Research | Full Text Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13058-019-1177-1/MediaObjects/13058_2019_1177_Fig5_HTML.png)
Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis | Breast Cancer Research | Full Text
![The influence of the blood–brain barrier in the treatment of brain tumours - Rathi - 2022 - Journal of Internal Medicine - Wiley Online Library The influence of the blood–brain barrier in the treatment of brain tumours - Rathi - 2022 - Journal of Internal Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2e567d9f-a88f-4e5a-a4ca-1692f40c2169/joim13440-fig-0003-m.jpg)
The influence of the blood–brain barrier in the treatment of brain tumours - Rathi - 2022 - Journal of Internal Medicine - Wiley Online Library
![Neratinib for the treatment of early-stage, hormone receptor-positive, HER2-overexpressed breast cancer | Future Oncology Neratinib for the treatment of early-stage, hormone receptor-positive, HER2-overexpressed breast cancer | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon-2020-0046/asset/images/medium/figure1.gif)
Neratinib for the treatment of early-stage, hormone receptor-positive, HER2-overexpressed breast cancer | Future Oncology
![PDF) Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis PDF) Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis](https://i1.rgstatic.net/publication/335156205_Neoadjuvant_neratinib_promotes_ferroptosis_and_inhibits_brain_metastasis_in_a_novel_syngeneic_model_of_spontaneous_HER2ve_breast_cancer_metastasis/links/5d535ef0458515304072e00e/largepreview.png)
PDF) Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis
![Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis | Breast Cancer Research | Full Text Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13058-019-1177-1/MediaObjects/13058_2019_1177_Fig2_HTML.png)
Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis | Breast Cancer Research | Full Text
![Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies | British Journal of Cancer Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-021-01424-8/MediaObjects/41416_2021_1424_Fig1_HTML.png)
Breast cancer brain metastasis: insight into molecular mechanisms and therapeutic strategies | British Journal of Cancer
![Mechanism, safety and efficacy of three tyrosine kinase inhibitors lapatinib, neratinib and pyrotinib in HER2-positive breast cancer. - Abstract - Europe PMC Mechanism, safety and efficacy of three tyrosine kinase inhibitors lapatinib, neratinib and pyrotinib in HER2-positive breast cancer. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6834479/bin/ajcr0009-2103-t2.jpg)
Mechanism, safety and efficacy of three tyrosine kinase inhibitors lapatinib, neratinib and pyrotinib in HER2-positive breast cancer. - Abstract - Europe PMC
![IJMS | Free Full-Text | Navigating the Blood–Brain Barrier: Challenges and Therapeutic Strategies in Breast Cancer Brain Metastases IJMS | Free Full-Text | Navigating the Blood–Brain Barrier: Challenges and Therapeutic Strategies in Breast Cancer Brain Metastases](https://www.mdpi.com/ijms/ijms-24-12034/article_deploy/html/images/ijms-24-12034-g002.png)
IJMS | Free Full-Text | Navigating the Blood–Brain Barrier: Challenges and Therapeutic Strategies in Breast Cancer Brain Metastases
![Neratinib in HER2-Positive Breast Cancer Patients - Rutugandha Paranjpe, Dima Basatneh, Gabriel Tao, Carmine De Angelis, Sobia Noormohammed, Ekim Ekinci, Susan Abughosh, Romi Ghose, Meghana V. Trivedi, 2019 Neratinib in HER2-Positive Breast Cancer Patients - Rutugandha Paranjpe, Dima Basatneh, Gabriel Tao, Carmine De Angelis, Sobia Noormohammed, Ekim Ekinci, Susan Abughosh, Romi Ghose, Meghana V. Trivedi, 2019](https://journals.sagepub.com/cms/10.1177/1060028018824088/asset/images/large/10.1177_1060028018824088-fig1.jpeg)